ResearchAuthor Correction: Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics
ResearchA cluster randomized trial of Visitect CD4 Advanced Disease platform among outpatients with advanced HIV disease in Uganda
ResearchAnalytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal cultures
ResearchDevelopment Framework of Desirability of Outcome Ranking Endpoints for Use in Clinical Trials of Invasive Fungal Diseases
ResearchHeadache as a Predictor of Cryptococcal Meningitis in Ambulatory Patients With Symptomatic HIV-associated Cryptococcal Antigenemia
ResearchAetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trial
ResearchPrevalence of CSF HIV VIRAL Escape and Associations With Neurocognitive Outcomes Among HIV-Associated Meningitis Survivors: A Cohort Study
ResearchFalse-Positive IMMY(®) Serum Cryptococcal Antigen Lateral Flow Assay Results Due to Improper Use of Titration Buffer
Feb 25, 2026Journal ArticleC-Reactive Protein in Tuberculous Meningitis: A Viable Biomarker for Individualized Care.Written by 2 Roon authors & 5 others Via Clinical Infectious Diseases
ResearchLumbar puncture frequency and patient survival among persons hospitalized with cryptococcal meningitis in the United States
ResearchInpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
ResearchUse of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial